Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Yarranton

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Clinical Pathology|February 3, 2000
Granulocytic sarcoma preceding AML M0 and the diagnostic value of CD34E Astall, H Yarranton, J Arno, et al.
Anaesthesia|November 6, 2012
Haemophagocytic lymphohistiocytosis in a patient with severe burnsJ R S Porter, J Handy, H Yarranton, et al.
Transfusion Medicine (Oxford, England)|March 27, 2004
Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpuraH Yarranton, A S Lawrie, G Purdy, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Clinical Pathology|February 3, 2000
Granulocytic sarcoma preceding AML M0 and the diagnostic value of CD34E Astall, H Yarranton, J Arno, et al.
Anaesthesia|November 6, 2012
Haemophagocytic lymphohistiocytosis in a patient with severe burnsJ R S Porter, J Handy, H Yarranton, et al.
Transfusion Medicine (Oxford, England)|March 27, 2004
Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpuraH Yarranton, A S Lawrie, G Purdy, et al.
Pageof 1